How should insulin glargine (Lantus) be dosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Dose Lantus (Insulin Glargine)

For type 2 diabetes patients not currently on insulin, start Lantus at 10 units once daily (or 0.2 units/kg), administered subcutaneously at the same time each day, and titrate by 2 units every 3 days until fasting blood glucose reaches target (<100 mg/dL). 1

Initial Dosing by Patient Type

Type 2 Diabetes (Insulin-Naïve)

  • Starting dose: 10 units once daily OR 0.2 units/kg 1
  • Administer at any consistent time of day (morning or bedtime equally effective) 2
  • Continue metformin; consider discontinuing other oral agents 3

Type 1 Diabetes

  • Starting dose: Approximately one-third of total daily insulin requirements 1
  • Must combine with short-acting prandial insulin for remaining two-thirds 1
  • Can be administered before breakfast, dinner, or bedtime with similar efficacy 4

Hospitalized Patients (Non-Critical Care)

Calculate total daily insulin dose based on blood glucose and patient characteristics 3:

  • 0.2-0.3 units/kg/day for patients:

    • Age ≥70 years, OR
    • GFR <60 mL/min
  • 0.4 units/kg/day for patients with blood glucose 140-200 mg/dL

  • 0.5 units/kg/day for patients with blood glucose 201-400 mg/dL

Distribute as 50% basal insulin (Lantus) and 50% nutritional (prandial) insulin 3

Titration Strategy

Outpatient Titration

Standard algorithm 5, 6:

  • Set fasting plasma glucose target (<100 mg/dL)
  • Increase dose by 2 units every 3 days until target reached without hypoglycemia
  • For hypoglycemia without clear cause, reduce dose by 10-20%

Alternative patient-managed titration 7:

  • Increase by 2 units every 3 days if fasting blood glucose remains elevated
  • Hold increase if blood glucose <72 mg/dL (<4.0 mmol/L)

Signs of Overbasalization

Consider adding prandial insulin or GLP-1 RA when 5:

  • Basal dose exceeds ~0.5 units/kg/day
  • Elevated bedtime-to-morning glucose differential
  • Hypoglycemia (aware or unaware)
  • High glucose variability

Converting from Other Insulins

From NPH Insulin

  • Once-daily NPH → Once-daily Lantus: Use same dose 1
  • Twice-daily NPH → Once-daily Lantus: Use 80% of total NPH dose 1
    • This dose reduction reduces hypoglycemia risk

Timing Flexibility

Lantus can be administered at any consistent time daily with equivalent efficacy 2, 4:

  • Morning administration: Lower nocturnal hypoglycemia (59.5% vs 77.5% bedtime) 4
  • Bedtime administration: Traditional timing, equally effective 2
  • Before dinner: Intermediate option 4

Administration Technique

Critical Points

  • Subcutaneous injection only - never intravenous or via insulin pump 1
  • Rotate injection sites within same region (abdomen, thigh, deltoid) 1
  • Inject at least 1 cm from previous injection sites 8
  • Allow refrigerated insulin to reach room temperature (30-60 minutes) before injection 8
  • Administer at 90-degree angle into subcutaneous tissue 8

Storage

  • Unopened: Refrigerate at 2-8°C (36-46°F) 8
  • Opened: Room temperature 15-30°C (59-86°F) for up to 28 days 8

Special Populations

Elderly or Renal Impairment

  • Start conservatively at 0.2-0.3 units/kg/day 3
  • Use insulin-sensitive correction scale 3
  • Monitor closely for hypoglycemia

NPO/Fasting Patients

  • Continue basal insulin alone 3
  • Add correction doses with rapid-acting insulin every 4 hours 3
  • Hold prandial insulin 3

Common Pitfalls to Avoid

Never use sliding-scale insulin alone - this triples hyperglycemia risk and provides inadequate control 3

Don't underdose - inadequate titration is the most common error; continue increasing dose every 3 days until fasting glucose reaches target 5, 7

Avoid therapeutic inertia - reassess and modify treatment every 3-6 months 5

Don't share insulin pens between patients - risk of blood-borne disease transmission 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.